Mechanism of action of levonorgestrel: in vitro metabolism and specific interactions with steroid receptors in target organs.
Levonorgestrel (LNG) is a synthetic steroid that displays potent progestational and androgenic effects but it lacks estrogen-like activity. To examine the mode of action of this progestin, we studied its metabolism in vitro in target organs and the specific interactions of LNG and its metabolites with putative steroid receptors. The results demonstrated that [3H]LNG was efficiently converted to A-ring reduced derivatives when incubated with rat hypothalamus and pituitary. Under optimal incubation conditions, [3H]5 alpha-dihydro LNG (5 alpha-LNG) and [3H]3 alpha,5 alpha-tetrahydro LNG (3 alpha,5 alpha-LNG) were identified as the major metabolic conversion products, while [3H]3 beta,5 alpha-LNG formation occurred to a lesser extent. A-ring reduction of LNG was NADPH-dependent. Assessment of the relative binding affinities of LNG and its derivatives to progesterone (PR), androgen (AR) and estrogen (ER) receptors by displacement analysis revealed that unchanged LNG binds with high affinity to PR and AR but not to ER. 5 alpha-LNG exhibited a diminished though significant interaction with PR and an enhanced binding affinity for AR as compared with LNG, indicating that 5 alpha-reduction of LNG increases its affinity for AR. The most striking finding was that further reduction of the 5 alpha-LNG molecule at C-3 abolished its binding activity to PR, AR, and even to ER. The overall data provides a plausible explanation for the lack of estrogen agonistic action of LNG and for its potent progestational and androgenic effects.
Lemus
A E
AE
Department of Reproductive Biology, National Institute of Nutrition S. Zubirán, Mexico City, Mexico.
Vilchis
F
F
Damsky
R
R
Chávez
B A
BA
García
G A
GA
Grillasca
I
I
Pérez-Palacios
G
G
D000818:Animals; D001711:Biotransformation; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D007031:Hypothalamus / Q000378:metabolism*; D007700:Kinetics; D016912:Levonorgestrel / Q000378:metabolism* / Q000494:pharmacology; D008297:Male; D009919:Orchiectomy; D009928:Organ Specificity; D010052:Ovariectomy; D010903:Pituitary Gland, Anterior / Q000378:metabolism*; D011467:Prostate / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D011944:Receptors, Androgen / Q000187:drug effects / Q000378:metabolism*; D011960:Receptors, Estrogen / Q000187:drug effects / Q000378:metabolism*; D011980:Receptors, Progesterone / Q000378:metabolism; D014599:Uterus / Q000378:metabolism*
D011944:Receptors, Androgen; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D004958:Estradiol; D016912:Levonorgestrel